Oct 1 (Reuters) – Sanofi and US partner Regeneron on Thursday said they would expand their partnership to develop four new drugs, in a deal that includes up to $7 billion in milestone payments. Sanofi
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: ATP 500 JAPAN OPEN FIRST ROUND HIGHLIGHTS COMPLETE SHOTLIST TO FOLLOW SHOWS: TOKYO,…
By Kate Abnett, Jarrett Renshaw and John Irish WASHINGTON/BRUSSELS/PARIS, Oct 1 (Reuters) - The Trump…
By Phuong Nguyen and Mas Alina Arifin HANOI, Oct 1 (Reuters) - Vietnam's coffee market…
VIDEO SHOWS: HIGHLIGHTS OF THE MLB WILD CARD SERIES GAME BETWEEN THE BOSTON RED SOX…
SYDNEY, Oct 1 (Reuters) - Influential proxy adviser Institutional Shareholder Services has urged Australian Securities…
SYDNEY, Oct 1 (Reuters) - Influential proxy adviser Institutional Shareholder Services has urged Australian Securities…